Impact of belatacept and tacrolimus on cytomegalovirus viral load control and relapse in moderate and high‐risk cytomegalovirus serostatus kidney transplant recipients

BACKGROUND: Belatacept improves long‐term graft survival, but control of some primary viral infections may be impaired. We evaluated the impact of belatacept and tacrolimus on cytomegalovirus (CMV) viral control, remission and relapse in CMV high‐risk and moderate‐risk recipients. METHODS: Using a m...

Descripción completa

Detalles Bibliográficos
Autores principales: Magua, Wairimu, Johnson, Aileen C., Karadkhele, Geeta M., Badell, Idelberto R., Vasanth, Payaswini, Mehta, Aneesh K., Easley, Kirk A., Newell, Kenneth A., Rickert, Joseph B., Larsen, Christian P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078597/
https://www.ncbi.nlm.nih.gov/pubmed/36321801
http://dx.doi.org/10.1111/tid.13983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078597/
https://www.ncbi.nlm.nih.gov/pubmed/36321801
http://dx.doi.org/10.1111/tid.13983

Ejemplares similares